Evidence map›Paper›PMID 33707464›Full record

ArticleScientific reports2021

Higher PGD

Shintaro Mishima, Jun-Ichi Kashiwakura, Shota Toyoshima, Tomomi Sasaki-Sakamoto, Yutaka Sano, Kazuyoshi Nakanishi, Kenji Matsumoto, Yoshimichi Okayama

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shintaro Mishima *Allergy and Immunology Research Project Team, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.
Jun-Ichi Kashiwakura *Allergy and Immunology Research Project Team, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.
Shota Toyoshima *Allergy and Immunology Research Project Team, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.
Tomomi Sasaki-SakamotoAllergy and Immunology Research Project Team, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.
Yutaka SanoAllergy and Immunology Research Project Team, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.
Kazuyoshi NakanishiDepartment of Orthopaedic Surgery, Nihon University School of Medicine, Tokyo, Japan.
Kenji MatsumotoDepartment of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
Yoshimichi OkayamaAllergy and Immunology Research Project Team, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan. okayama.yoshimichi@nihon-u.ac.jp.
Nihon University · JPNational Center For Child Health and Development · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported that synovial mast cells (MCs) from patients with rheumatoid arthritis (RA) produced TNF-α in response to immune complexes via FcγRI and FcγRIIA. However, the specific functions of synovial MCs in RA remain unclear. This study aimed to elucidate those functions. Synovial tissues and fluid were obtained from RA and osteoarthritis (OA) patients undergoing joint replacement surgery. Synovium-derived, cultured MCs were generated by culturing dispersed synovial cells with stem cell factor. We performed microarray-based screening of mRNA and microRNA (miRNA), followed by quantitative RT-PCR-based verification. Synovial MCs from RA patients showed significantly higher prostaglandin systhetase (PTGS)1 and PTGS2 expression compared with OA patients' MCs, and they produced significantly more prostaglandin D

Indexed as

Signal TransductionAgedAged, 80 and overArthritis, RheumatoidCells, CulturedCyclooxygenase 1Cyclooxygenase 2DinoprostoneFemaleFibroblastsGene Expression ProfilingGene Expression RegulationHistamine ReleaseHumansImmunity, InnateInterleukin-8Cyclooxygenase 1Cyclooxygenase 2DinoprostoneFc gamma receptor IIAInterleukin-8MicroRNAsmirn199 microRNA, humanProstaglandin D2PTGS1 protein, humanPTGS2 protein, humanReceptors, IgGRNA, Messenger

Identifiers

PMID33707464
PMCPMC7952410
OpenAlexW3135104261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.